Organon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age

AI Briefing

• – Organon's VTAMA cream, 1%, shows early and consistent skin clearance and itch improvements in Atopic Dermatitis patients down to 2 years of age.
• – New Phase 3 pooled data analysis reveals significant results.
• – VTAMA cream, 1%, demonstrates effectiveness for AD patients of all ages.